Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term Follow-up of Pemphigus Patients From RITUXIMAB 3 Trial
NCT03790293Phase 3Completed
- Sponsor
- Rouen University Hospital
- Start
- Nov 2018
- Primary completion
- Apr 2019
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of rituximab in pemphigus, sponsored by Rouen University Hospital. Started Nov 2018; status: completed.
02
Drugs
rituximab
03
Conditions
pemphigus
Beyond the preview
Go deeper on NCT03790293.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03790293.